We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Zillow
Z
$8.07B
| $2.9M | 0.01% |
45,500
+9,500
| +26% | +$510K |
|
552
Bunge Global
BG
$21.7B
| $2.88M | 0.01% |
29,800
+5,700
| +24% | +$583K |
|
553
Globus Medical
GMED
$11.5B
| $2.87M | 0.01% |
40,097
+11,200
| +39% | +$791K |
|
554
Duolingo
DUOL
$6.65B
| $2.82M | 0.01% |
10,000
+2,500
| +33% | +$513K |
|
555
Evercore
EVR
$11.8B
| $2.8M | 0.01% |
11,037
+4,100
| +59% | +$976K |
|
556
Tapestry
TPR
$26B
| $2.79M | 0.01% |
59,346
| – | – |
|
557
Rollins
ROL
$17.5B
| $2.78M | 0.01% |
55,024
+5,511
| +11% | +$272K |
|
558
Federal Realty Investment Trust
FRT
$10.3B
| $2.78M | 0.01% |
24,200
+8,600
| +55% | +$960K |
|
559
Crown Holdings
CCK
$13B
| $2.78M | 0.01% |
29,000
+2,000
| +7% | +$172K |
|
560
Regions Financial
RF
$27B
| $2.78M | 0.01% |
118,979
-3,681
| -3% | -$80.4K |
|
561
C.H. Robinson
CHRW
$17.6B
| $2.77M | 0.01% |
25,100
+6,700
| +36% | +$651K |
|
562
Assurant
AIZ
$13.9B
| $2.72M | 0.01% |
13,700
+4,400
| +47% | +$802K |
|
563
Onto Innovation
ONTO
$20.9B
| $2.72M | 0.01% |
13,100
+2,500
| +24% | +$505K |
|
564
Global E Online
GLBE
$7.09B
| $2.71M | 0.01% |
70,558
| – | – |
|
565
Hasbro
HAS
$13.6B
| $2.71M | 0.01% |
37,400
+6,000
| +19% | +$389K |
|
566
Carlyle Group
CG
$18B
| $2.7M | 0.01% |
62,800
+25,400
| +68% | +$1.07M |
|
567
Laureate Education
LAUR
$5.16B
| $2.7M | 0.01% |
162,702
-22,500
| -12% | -$344K |
|
568
Kinsale Capital Group
KNSL
$8.57B
| $2.7M | 0.01% |
5,800
+1,000
| +21% | +$442K |
|
569
Brixmor Property Group
BRX
$9.18B
| $2.67M | 0.01% |
96,000
+4,200
| +5% | +$108K |
|
570
Akamai
AKAM
$18B
| $2.67M | 0.01% |
26,486
| – | – |
|
571
Dick's Sporting Goods
DKS
$18.1B
| $2.67M | 0.01% |
12,800
-100
| -0.8% | -$21.4K |
|
572
Twilio
TWLO
$38.9B
| $2.66M | 0.01% |
40,800
| – | – |
|
573
TD Synnex
SNX
$20.5B
| $2.66M | 0.01% |
22,142
+9,100
| +70% | +$1.05M |
|
574
Omega Healthcare
OHI
$14B
| $2.64M | 0.01% |
64,913
+12,600
| +24% | +$477K |
|
575
Ascendis Pharma A/S
ASND
$16.2B
| $2.64M | 0.01% |
17,667
+4,200
| +31% | +$567K |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.